Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-01-25

FDA Approved: ZOLOFT — Supplemental Application (ROERIG)

View source ↗

Summary

The FDA approved a supplemental application for Zoloft (sertraline hydrochloride) filed by Roerig.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Zoloft (sertraline)

Snippet

SUPPL AP for ZOLOFT (SERTRALINE HYDROCHLORIDE)